Lilly Strattera Medicaid Reimbursement In 42 States; Launch Beats Lexapro
Executive Summary
Lilly's Strattera has gained Medicaid reimbursement in 42 states in the three months since the launch of the attention deficit disorder drug, Investor Relations Manager Craig Hartman told investors April 22
You may also be interested in...
Lilly Remains Attentive To Corporate Affairs; Strattera Head Nobles Named VP
Lilly Strattera Product Team Leader Anne Nobles will focus her attention on public policy and communications issues as the firm's new VP-corporate affairs, effective June 1
Lilly Remains Attentive To Corporate Affairs; Strattera Head Nobles Named VP
Lilly Strattera Product Team Leader Anne Nobles will focus her attention on public policy and communications issues as the firm's new VP-corporate affairs, effective June 1
Lilly Strattera Disease Awareness Campaign Will Focus On Adult ADHD
Lilly is designing a disease awareness campaign targeting adults for its attention deficit and hyperactivity disorder product Strattera